A Phase Ia/II, Single Arm Trial on the Efficacy of Vemurafenib in Combination With Irinotecan and Cetuximab in BRAF V600E-Mutant Metastatic Colorectal Cancer
Latest Information Update: 21 Feb 2023
At a glance
- Drugs Cetuximab (Primary) ; Irinotecan (Primary) ; Vemurafenib (Primary)
- Indications Colon cancer; Colorectal cancer
- Focus Therapeutic Use
- 13 Feb 2023 Status changed from recruiting to completed.
- 15 Mar 2021 New trial record